Cost-effective treatment of pseudomembranous colitis.
McKenna
J P
JP
Chamovitz
B N
BN
D003362:Cost-Benefit Analysis; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation; D014640:Vancomycin / Q000008:administration & dosage*
D008795:Metronidazole; D014640:Vancomycin